Skip to main content
. 2017 Apr 20;14:85. doi: 10.1186/s12974-017-0861-2

Fig. 4.

Fig. 4

Serum APN levels (μg/ml) in patients affected by different neurological diseases (ALS amyotrophic lateral sclerosis, FTD fronto-temporal dementia, DN dysimmuno-neuropathy, AD Alzheimer’s disease, OND other neurological diseases) when compared to CTR. Mean ± SE is reported. *p < 0.05, **p < 0.01, ***p < 0.001